A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder

Top Cited Papers
Open Access
Abstract
BIPOLAR DISORDER is a chronic, severe disease with a prevalence of approximately 1.6% for the bipolar I form and more than 3% when other forms are included.1-3 Social and vocational morbidity is high, and the mortality rate from suicide is estimated to be 3 times that of the general population.4,5 Nine of 10 patients with an initial episode of mania experience subsequent manic, hypomanic, depressed, or mixed episodes that are characterized by significant cognitive and behavioral dysfunction as well as mood impairment.6 Each additional mood episode increases the risk of future recurrences and worsens the prognosis.7,8 Therefore, although effective treatment of acute mood episodes in bipolar disorder is important, a primary treatment objective is the prevention of subsequent mood episodes.9-11